Omar M. Aly

1.2k total citations
50 papers, 902 citations indexed

About

Omar M. Aly is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Omar M. Aly has authored 50 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 24 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Omar M. Aly's work include Synthesis and biological activity (18 papers), Click Chemistry and Applications (7 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). Omar M. Aly is often cited by papers focused on Synthesis and biological activity (18 papers), Click Chemistry and Applications (7 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). Omar M. Aly collaborates with scholars based in Egypt, Saudi Arabia and United States. Omar M. Aly's co-authors include Mai E. Shoman, Usama Ramadan Abdelmohsen, Muhamad Mustafa, Amira M. Gamal‐Eldeen, Mohamed Kamel, Eman A. M. Beshr, Asmaa I. Owis, Gamal El‐Din A. Abuo‐Rahma, Elshimaa M. N. Abdelhafez and Mohamed Abdel‐Aziz and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecules and RSC Advances.

In The Last Decade

Omar M. Aly

47 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omar M. Aly Egypt 18 442 306 162 74 71 50 902
Muhammad Khattab Egypt 14 335 0.8× 281 0.9× 188 1.2× 64 0.9× 53 0.7× 28 878
Sarfaraz Alam India 18 453 1.0× 384 1.3× 222 1.4× 85 1.1× 96 1.4× 40 1.0k
Vaishali M. Patil India 15 285 0.6× 246 0.8× 161 1.0× 45 0.6× 98 1.4× 76 810
Hamadeh Tarazi United Arab Emirates 17 287 0.6× 338 1.1× 97 0.6× 41 0.6× 131 1.8× 37 769
Temitope Isaac Adelusi Nigeria 16 166 0.4× 427 1.4× 218 1.3× 64 0.9× 66 0.9× 45 851
Maria Maddalena Cavalluzzi Italy 19 300 0.7× 515 1.7× 121 0.7× 96 1.3× 145 2.0× 65 1.1k
Suvarna G. Kini India 17 684 1.5× 475 1.6× 181 1.1× 39 0.5× 112 1.6× 67 1.3k
Dilep Kumar Sigalapalli India 20 717 1.6× 508 1.7× 119 0.7× 70 0.9× 115 1.6× 48 1.2k
Abdelsattar M. Omar Saudi Arabia 19 522 1.2× 370 1.2× 93 0.6× 33 0.4× 113 1.6× 67 942
Gonçalo C. Justino Portugal 16 292 0.7× 323 1.1× 84 0.5× 73 1.0× 81 1.1× 36 1.0k

Countries citing papers authored by Omar M. Aly

Since Specialization
Citations

This map shows the geographic impact of Omar M. Aly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar M. Aly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar M. Aly more than expected).

Fields of papers citing papers by Omar M. Aly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar M. Aly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar M. Aly. The network helps show where Omar M. Aly may publish in the future.

Co-authorship network of co-authors of Omar M. Aly

This figure shows the co-authorship network connecting the top 25 collaborators of Omar M. Aly. A scholar is included among the top collaborators of Omar M. Aly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar M. Aly. Omar M. Aly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saber, Abdullah A., Omar M. Aly, Wedad M. Abdelraheem, et al.. (2024). Cosmopolitan but still untapped: Antimicrobial, antibiofilm and in silico molecular docking study on Caulerpa racemosa, Dictyopteris polypodioides and Padina pavonica. Algal Research. 85. 103837–103837. 2 indexed citations
3.
Bender, Onur, İsmail Çeli̇k, Amer Ali Abd El‐Hafeez, et al.. (2024). Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor. Pharmaceuticals. 17(5). 659–659. 4 indexed citations
4.
Bender, Onur, Jonaid Ahmad Malik, Arzu Atalay, et al.. (2023). Combination of an Oxindole Derivative with (−)-β-Elemene Alters Cell Death Pathways in FLT3/ITD+ Acute Myeloid Leukemia Cells. Molecules. 28(13). 5253–5253. 3 indexed citations
5.
Attia, Eman Zekry, et al.. (2023). In Vitro Cytotoxic Potential of Ethanol Extract of Dictyopteris acrostichoides Against Human Cancer Cells. Revista Brasileira de Farmacognosia. 34(1). 212–216. 5 indexed citations
6.
Mustafa, Muhamad, et al.. (2023). Hydantoin derivatives: A review on their anticancer activities. 0(0). 0–0. 3 indexed citations
7.
Metwally, Kamel, Nader E. Abo‐Dya, Ahmed M. Hamdan, et al.. (2023). Investigation of Simultaneous and Sequential Cooperative Homotropic Inhibitor Binding to the Catalytic Chamber of SARS-CoV-2 RNA-dependent RNA Polymerase (RdRp). Cell Biochemistry and Biophysics. 81(4). 697–706.
8.
Abdel-Rahman, Iman A. M., et al.. (2022). Metabolite profiling of green algae Halimeda opuntia to target hepatitis C virus-796 polymerase inhibitors assisted by molecular docking. South African Journal of Botany. 151. 538–543. 9 indexed citations
9.
Mustafa, Muhamad, et al.. (2022). Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFRL858R/T790M Mutations. Pharmaceuticals. 15(7). 857–857. 5 indexed citations
10.
Marzouk, Adel A., et al.. (2020). Design, synthesis and anticonvulsant activity of new imidazolidindione and imidazole derivatives. Bioorganic Chemistry. 101. 104020–104020. 35 indexed citations
11.
Mustafa, Muhamad, et al.. (2019). Potent combretastatin A-4 analogs containing 1,2,4-triazole: Synthesis, antiproliferative, anti-tubulin activity, and docking study. European Journal of Medicinal Chemistry. 183. 111697–111697. 42 indexed citations
12.
Beshr, Eman A. M., et al.. (2018). Spirohydantoins and 1,2,4-triazole-3-carboxamide derivatives as inhibitors of histone deacetylase: Design, synthesis, and biological evaluation. European Journal of Medicinal Chemistry. 146. 79–92. 32 indexed citations
13.
Gayvert, Kaitlyn, Omar M. Aly, James T. Platt, et al.. (2017). A Computational Approach for Identifying Synergistic Drug Combinations. PLoS Computational Biology. 13(1). e1005308–e1005308. 66 indexed citations
14.
Taye, Ashraf, et al.. (2017). Enhanced anticancer effect of Combretastatin A-4 phosphate when combined with vincristine in the treatment of hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 89. 36–46. 20 indexed citations
15.
Hadimani, Mallinath B., et al.. (2015). Ring expansions of acyloxy nitroso compounds. Tetrahedron Letters. 56(43). 5870–5873. 11 indexed citations
16.
Abdel‐Aziz, Mohamed, Kamel Metwally, Amira M. Gamal‐Eldeen, & Omar M. Aly. (2015). 1,3,4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities. Anti-Cancer Agents in Medicinal Chemistry. 16(2). 269–277. 14 indexed citations
17.
18.
Abdel‐Aziz, Mohamed, et al.. (2012). Synthesis, Cytotoxic Properties and Tubulin Polymerization Inhibitory Activity of Novel 2‐Pyrazoline Derivatives. Archiv der Pharmazie. 345(7). 535–548. 21 indexed citations
19.
Abuo‐Rahma, Gamal El‐Din A., et al.. (2008). Design, synthesis and hypolipidemic activity of novel 2-(m-tolyloxy) isobutyric acid derivatives. European Journal of Medicinal Chemistry. 44(6). 2679–2684. 6 indexed citations
20.
Khoobehi, Bahram, et al.. (1990). Determination of retinal blood velocity with respect to the cardiac cycle using laser‐Triggered release of liposome‐Encapsulated dye. Lasers in Surgery and Medicine. 10(5). 469–475. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026